Some farmers in New York grow special plants called cannabis that people use for medicine or fun. But they are having trouble selling their plants because there aren't enough stores to buy them. They asked the government for help by giving them money, but the government said no. Now the farmers are sad and losing a lot of money. Read from source...

- The article title is misleading and sensationalist. It implies that the excluded relief fund was meant for all New York cannabis farmers, when in fact it was a proposal by some legislators to help struggling farmers who faced financial losses due to limited retail outlets and oversupply of cannabis products in the market.
- The article lacks proper contextualization and background information on the legal status of cannabis in New York, the regulatory framework, and the challenges faced by cannabis farmers and businesses operating in the state.
- The article focuses mainly on the negative aspects of the situation, such as financial losses, disappointment, and lack of support from the budget committee, without exploring possible solutions or alternatives for the affected farmers, such as diversifying their products, expanding their market reach, or seeking partnerships with other cannabis companies.
- The article relies on quotes from two legislators who advocated for the relief fund, without giving equal voice to any opposing views or perspectives from other stakeholders, such as the state budget committee, the governor's office, or the cannabis industry associations. This creates a biased and one-sided presentation of the issue.
- The article uses emotional language and phrases, such as "struggling", "excluded", "dismissed", "grappling with significant financial losses", to evoke sympathy and outrage from the readers, without providing factual evidence or data to support these claims. This makes the article seem more like an opinion piece than a balanced news report.
- The article ends abruptly and without any conclusion, implying that there is no hope or resolution for the situation of the cannabis farmers in New York. This leaves the readers feeling unsatisfied and uninformed.

Negative

Summary:
New York cannabis farmers are facing financial losses and struggling due to the exclusion of the proposed Cannabis Farmer’s Relief Fund from the state budget. Legislators who advocated for the fund expressed their disappointment over the lack of support during budget discussions. The situation is worsened by the limited number of retail outlets available for selling their products in 2022 and 2023, resulting in a flooded market with unsold cannabis.

1. Avoid investing in NY state-based cannabis companies or ETFs until the market conditions improve and the regulatory environment becomes more favorable for growers. The current situation presents significant downside risk and uncertainty, as well as limited upside potential. Some examples of such products are Cresco Labs (CRLBF), Columbia Care (CCHW), and Jushi Holdings (JUSH).
2. Consider investing in cannabis companies or ETFs that have a diversified geographic footprint, especially those with exposure to other states where the legal environment is more conducive for growth and profitability. Some examples of such products are Curaleaf (CURLF), Green Thumb Industries (GTBIF), and Trulieve Cannabis (TCNNF).
3. Another option is to invest in cannabis companies or ETFs that focus on the medical or wellness segments, as these areas tend to be less affected by regulatory challenges and market fluctuations. Some examples of such products are GW Pharmaceuticals (GWPH), Insys Therapeutics (INSY), and Zynerba Pharmaceuticals (ZYNE).
4. Alternatively, you could also consider investing in cannabis companies or ETFs that have a strong balance sheet, robust cash flow, and sustainable growth prospects, regardless of their geographic exposure. Some examples of such products are Canopy Growth (CGC), Aurora Cannabis (ACB), and Tilray (TLRY).
5. Finally, you could also consider investing in cannabis companies or ETFs that have significant exposure to the international market, especially those with operations in countries where cannabis is fully legalized or decriminalized, such as Canada, Germany, Israel, and Australia. Some examples of such products are Canopy Growth (CGC), Aurora Cannabis (ACB), and Tilray (TLRY).